The DOI matches its Crossref record.
Intensive Insulin Therapy and Weight Gain in IDDM
Abstract
Intensive insulin therapy is frequently complicated by excessive weight gain. The purpose of this study was to determine the cause and composition of this weight gain. Therefore, changes in body composition, energy expenditure, glycosuria, and substrate kinetics were evaluated in patients with IDDM who transferred from conventional insulin therapy to intensive insulin therapy. Six adult patients with IDDM were studied on conventional insulin therapy and after 2 mo of intensive insulin therapy while maintaining constant caloric intake and were compared with a group of 6 matched nondiabetic volunteers. Body composition was determined by underwater weighing. Energy expenditure was measured during 24-h stays in a whole-room calorimeter. Whole-body turnover rates of glucose, glycerol, palmitate, and leucine were determined by isotope dilution methods. Intensive insulin therapy lowered the mean daily blood glucose concentration and HbA1 (14.8 ± 1.6 to 7.7 ± 0.6 mM and 12.9 ± 0.9 to 9.6 ± 0.6%, both P < 0.01) and almost eliminated glycosuria (428 ± 116 to 39 ± 22 mmol/day, P < 0.05). Body weight increased 2.6 ± 0.8 kg with intensive insulin therapy (P < 0.05) as a result of an increase in fat mass (2.4 ± 0.8 kg, P < 0.05). Daily energy expenditure decreased 5% (118 ± 32 kcal/day) with intensive insulin therapy (P < 0.05). The rates of glucose, glycerol, free fatty acid, and leucine turnover, triglyceride/free fatty acid cycling, and nonoxidative glucose and protein disposal were reduced in the diabetic volunteers during intensive insulin therapy. Thus, intensive insulin therapy causes an increase in body fat as a result of the elimination of glycosuria and reduction in 24-h energy expenditure. The elimination of glycosuria contributed 70% to the positive energy balance during intensive insulin therapy, and the reduction in 24-h energy expenditure contributed the remainder. The reduction in 24-h energy expenditure was the result of the decrease in triglyceride/free fatty acid cycling and nonoxidative glucose and protein metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanisms responsible for smaller weight losses in patients with diabetes may include reductions in resting metabolic rate, which occur with improved glycemic control (accompanying weight loss), decreased dietary adherence and “defensive snacking” related to fears of hypoglycemia, as well as reduced glycosuria.(49, 50)”
From Semaglutide for the treatment of obesity (2023) · cites this paper as [49]
In the citing paper
“Patients with type 1 diabetes undergoing intensification of insulin therapy for 2 mo experienced a 2.4-kg increase in body fat, associated with decreased energy expenditure and therefore not fully attributable to changes in dietary intake and urinary glucose excretion (70).”
From The carbohydrate-insulin model: A physiological perspective on the obesity pandemic (2021) · cites this paper as [70]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–154 of 154
Christou, M., Christou, P. A., Katsarou, D. N., Georga, E. I., Kyriakopoulos, C., Markozannes, G., Christou, G. A., Fotiadis, D. I., & Tigas, S. K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175303 · Cited by 8
Adaptation to Protein Restriction Is Impaired in Insulin-Dependent Diabetes Mellitus ,
Hoffer, L. J. (1998) · Journal of Nutrition · doi:10.1093/jn/128.2.333s · Cited by 7
Consequences of Weight Gain Associated With Insulin Therapy in Adolescents
KAUFMAN, F. R. (2006) · The Endocrinologist · doi:10.1097/01.ten.0000217883.47474.84 · Cited by 6
Kramer, K. L., Giffin, B. F., Fox, J. W., & Drake, R. L. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1299 · Cited by 6
Russ, R. D., & Tobin, B. W. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-4-407 · Cited by 6
The Data Behind Popular Diets for Weight Loss
Ehrlicher, S. E., Chui, T. K., Clina, J. G., Ellison, K. M., & Sayer, R. D. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.05.003 · Cited by 5
Tobin, B. W., Welch-Holland, K. R., & Marchello, M. J. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-8-622 · Cited by 5
Breum, L. (1986) · PubMed · Cited by 5
Effect of protein restriction on sulfur amino acid catabolism in insulin-dependent diabetes mellitus
Hamadeh, M. J., & Hoffer, L. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00295.2002 · Cited by 5
Carnero, E. Á., Corbin, K. D., Casu, A., IGUDESMAN, D. A., Bilal, A., Smith, S. R., Kosorok, M. R., Maahs, D. M., Mayer‐Davis, E. J., & Pratley, R. E. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01446-4 · Cited by 4
Muhammad, N., Rajput, N. A., Dong, L., Zhang, L., & Wang, T. Z. (2014) · Tropical Animal Health and Production · doi:10.1007/s11250-014-0671-9 · Cited by 4
Mitochondrial function in skeletal muscle in type 2 diabetes.
Rabøl, R. (2011) · PubMed · Cited by 4
Nateglinide with glibenclamide examination using the respiratory quotient (RQ)
Harada, S., Nomura, M., Nakaya, Y., & Ito, S. (2006) · The Journal of Medical Investigation · doi:10.2152/jmi.53.303 · Cited by 3
Moslemipur, F., Torbatinejad, N. M., Khazali, H., Hassani, S., & Ghoorchi, T. (2009) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2009.80626 · Cited by 3
Saki, F., Omrani, G. R., & Dabbaghmanesh, M. H. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0479-4 · Cited by 3
Mendonça, T. S., Oliveira, W. N., Belo, V. S., da Silva, E. S., Pereira, M. L., Obreli-Neto, P. R., & Baldoni, A. O. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00835-8 · Cited by 3
Role of insulin in management of type 2 diabetes mellitus
Patil, S. S., Mehta, M. N., Thakare, V., Shende, S. S., Shirure, P. A., & Swami, O. C. (2017) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20172422 · Cited by 2
Effects of Gold and Cerium Oxide Nanoparticles on Type 1 Diabetes in Experimental Mice
Alghamdi, J. M., & El‐Refaei, M. F. (2020) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2020.959.967 · Cited by 2
Miętkiewska-Dolecka, M., & Uruska, A. A. (2021) · Journal of Medical Science · doi:10.20883/medical.e531 · Cited by 2
Blood Glucose and Bodyweight in Type 2 Diabetes – Are These Compatible Treatment Targets?
Russell-Jones, D. L. (2008) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2008.04.02.31 · Cited by 2
Therapy of Type 1 Diabetes Mellitus
Cohan, P., & Peters, A. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_43 · Cited by 2
Glycemic control and complications of diabetes mellitus.
Hirsch, I. B. (1995) · PubMed Central · Cited by 2
Therapy of Type 1 Diabetes Mellitus
Omura, E., Cohan, P., & Peters, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_43-2 · Cited by 1
Fukuoka, M., Yasuhi, I., Yamashita, H., Ashimoto, K., Kurata, N., Yamaguchi, J., Koga, M., Sugimi, S., Suga, S., & Fukuda, M. (2023) · Journal of Diabetes Research · doi:10.1155/2023/9574563 · Cited by 1
Aiello, E. M., Toffanin, C., Riddell, M. C., Martin, C. K., Patton, S. R., Gal, R. L., & Doyle, F. J. (2025) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2025.111758 · Cited by 2
The Role of Diet and Lifestyle Modification in the Treatment of Polycystic Ovary Syndrome
Thomson, R. L., Teede, H. J., Stepto, N. K., Banting, L., & Moran, L. (2015) · CRC Press eBooks · doi:10.1201/b18190-3 · Cited by 1
The effect of 10- versus 30-minutes of acute aerobic exercise on insulin and glucose in obese adults
Mishler, A. E. (2012) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
(2007) · The Internet Journal of Advanced Nursing Practice · doi:10.5580/1ba5 · Cited by 1
The Impact of Carbohydrate Restriction and Nutritional Ketosis on Cardiovascular Health
Lowe, D. A., Corbit, K. C., & Weiss, E. J. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_5 · Cited by 1
Craciun, A. E., Bala, C. G., Craciun, C. I., Román, G., Georgescu, C. E., & Hâncu, N. (2014) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2014-0036 · Cited by 1
Eating to Improve Body Composition
António, J., & Manninen, A. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-302-8_26 · Cited by 1
Forouhi, N. G., & Wareham, N. J. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch7 · Cited by 1
A Practical Guide to Intensive Insulin Therapy
Campbell, P. J., & May, M. (1995) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199507000-00008 · Cited by 1
Self-citationConway, B. N. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Amiel, S. A. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch7
Leptin and insulin as adiposity signals
Niswender, K. D. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541643.005
Pre-dialysis insulin: a new concept to treat an old problem
Marchant, K. (2009) · British Journal of Nursing · doi:10.12968/bjon.2009.18.17.44157
Modifications de la composition de l'organisme à la phase initiale du diabète sucré de l'enfant
Giniès, J., Duveau, E., Beringue, F., Audran, M., & Limal, J. M. (1999) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(99)80022-3
Clinical appraisal of deficiencies of the basal analog insulin
King, A. B. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.47
Zachariah, S., & Russell-Jones, D. L. (2008) · Independent Nurse · doi:10.12968/indn.2008.2.5.75787
Experimental Study Using Cinnamon Oil for Prevention of Diabetic Nephropathy in Rats
Shaikh, M. N. A. –. (2010) · Iraqi postgraduate Medical Journal
Choosing Medications for Weight Loss in Type 2 Diabetes Mellitus
Jagasia, S. M., Hendrickson, C. D., & Williams, A. J. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch15
Therapy of Type 1 Diabetes Mellitus
Omura, E., & Peters, A. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_43-1
Therapy of Type 1 Diabetes Mellitus
Omura, E., Cohan, P., & Peters, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_43
Donato, J. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2005.tde-25082005-131015
Davidson, M. B. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80142-2
RATIONAL PHARMACEUTICAL THERAPY OF TYPE 2 DIABETES MELLITUS USING ENDOGEN PANCREAS RESERVES
Pilipenko, V. M., Skubin, V. M., Кushnareva, N. M., & Korpachova-Zinych, O. V. (2010) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2010.1.04
Chapter 10. Medication-Related Weight Changes: Impact on Treatment of Eating Disorder Patients
Powers, P. S., & Cloak, N. L. (2007) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377770.lg10
Bartochowski, P., Chwastek, J., Zglinicki, B., Pietrzyk, O., Olech-Kochańczyk, G., Szewc, M., Bartelik, A., Torres, J. C., Karpiński, A., Jaholkowski, P. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.06.625641
Treatment of Obesity in Individuals with Type 1 Diabetes
Almehthel, M. S., & Alshehri, A. (2024) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2024.2332
Recent advances in quantum dot-mediated delivery for antidiabetic drugs
Nagendraraj, T., Annaraj, J., Ananthappan, P., & Vasantha, V. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24064-5.00002-0
Mendonça, T. S., Oliveira, W. N., Belo, V. S., Silva, E. S., Pereira, M. L., Obreli-Neto, P. R., & Baldoni, A. O. (2022) · Figshare · doi:10.6084/m9.figshare.19695680
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
Yoo, J. H., Kim, S., Park, Y. J., Park, S., Chung, C. H., Kim, J. H., Kwak, S. H., & Kim, G. (2026) · Diabetes Care · doi:10.2337/dc26-1039
Metadata
- Authors
- Carlson, M. G., & Campbell, P. J.
- Affiliations
- Vanderbilt University (US)
- ORCID
- Campbell, Peter J
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1993-12-01
- Volume
- 42
- Issue
- 12
- Pages
- 1700-1707
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2119063869
- Cited by
- 155
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 9 · 2020: 4 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 2 · 2014: 4 · 2013: 9 · 2012: 3
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29dk041376-05)
- U.S. Public Health Service (P30-26657, P60 20593)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK41376)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- intensive insulin therapy, type 1 diabetes, weight gain, body composition, fat mass, energy expenditure, glycosuria, substrate kinetics, glucose turnover, nonoxidative glucose disposal, protein metabolism, HbA1c
- MeSH terms
- Adipose Tissue, Adult, Basal Metabolism, Blood Glucose, Diabetes Mellitus, Type 1, Fatty Acids, Nonesterified, Female, Glycerol, Humans, Insulin, Male, Weight Gain, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review